485 related articles for article (PubMed ID: 12970424)
1. An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector.
Perri S; Greer CE; Thudium K; Doe B; Legg H; Liu H; Romero RE; Tang Z; Bin Q; Dubensky TW; Vajdy M; Otten GR; Polo JM
J Virol; 2003 Oct; 77(19):10394-403. PubMed ID: 12970424
[TBL] [Abstract][Full Text] [Related]
2. Characterization of human immunodeficiency virus Gag-specific gamma interferon-expressing cells following protective mucosal immunization with alphavirus replicon particles.
Gupta S; Janani R; Bin Q; Luciw P; Greer C; Perri S; Legg H; Donnelly J; Barnett S; O'Hagan D; Polo JM; Vajdy M
J Virol; 2005 Jun; 79(11):7135-45. PubMed ID: 15890953
[TBL] [Abstract][Full Text] [Related]
3. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
[TBL] [Abstract][Full Text] [Related]
4. Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector.
Caley IJ; Betts MR; Irlbeck DM; Davis NL; Swanstrom R; Frelinger JA; Johnston RE
J Virol; 1997 Apr; 71(4):3031-8. PubMed ID: 9060663
[TBL] [Abstract][Full Text] [Related]
5. Characterization of immune responses elicited in macaques immunized sequentially with chimeric VEE/SIN alphavirus replicon particles expressing SIVGag and/or HIVEnv and with recombinant HIVgp140Env protein.
Xu R; Srivastava IK; Greer CE; Zarkikh I; Kraft Z; Kuller L; Polo JM; Barnett SW; Stamatatos L
AIDS Res Hum Retroviruses; 2006 Oct; 22(10):1022-30. PubMed ID: 17067273
[TBL] [Abstract][Full Text] [Related]
6. Alphavirus DNA and particle replicons for vaccines and gene therapy.
Polo JM; Gardner JP; Ji Y; Belli BA; Driver DA; Sherrill S; Perri S; Liu MA; Dubensky TW
Dev Biol (Basel); 2000; 104():181-5. PubMed ID: 11713818
[TBL] [Abstract][Full Text] [Related]
7. Effects of rapid antigen degradation and VEE glycoprotein specificity on immune responses induced by a VEE replicon vaccine.
Fluet ME; Whitmore AC; Moshkoff DA; Fu K; Tang Y; Collier ML; West A; Moore DT; Swanstrom R; Johnston RE; Davis NL
Virology; 2008 Jan; 370(1):22-32. PubMed ID: 17904185
[TBL] [Abstract][Full Text] [Related]
8. Increased immunogenicity of a DNA-launched Venezuelan equine encephalitis virus-based replicon DNA vaccine.
Ljungberg K; Whitmore AC; Fluet ME; Moran TP; Shabman RS; Collier ML; Kraus AA; Thompson JM; Montefiori DC; Beard C; Johnston RE
J Virol; 2007 Dec; 81(24):13412-23. PubMed ID: 17913817
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type 1 Gag-specific vaginal immunity and protection after local immunizations with sindbis virus-based replicon particles.
Vajdy M; Gardner J; Neidleman J; Cuadra L; Greer C; Perri S; O'Hagan D; Polo JM
J Infect Dis; 2001 Dec; 184(12):1613-6. PubMed ID: 11740739
[TBL] [Abstract][Full Text] [Related]
10. Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic.
Paessler S; Fayzulin RZ; Anishchenko M; Greene IP; Weaver SC; Frolov I
J Virol; 2003 Sep; 77(17):9278-86. PubMed ID: 12915543
[TBL] [Abstract][Full Text] [Related]
11. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses.
Paessler S; Ni H; Petrakova O; Fayzulin RZ; Yun N; Anishchenko M; Weaver SC; Frolov I
J Virol; 2006 Mar; 80(6):2784-96. PubMed ID: 16501087
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of human immunodeficiency virus type 1 subtype C gag, pol, and gagpol DNA and alphavirus replicon vaccines.
Megede JZ; Otten GR; Doe B; Liu H; Srivastava R; Greer C; Legg H; Tang T; Polo JM; Donnelly JJ; Ulmer JB; Barnett SW
Vaccine; 2006 Apr; 24(15):2755-63. PubMed ID: 16460840
[TBL] [Abstract][Full Text] [Related]
13. Utility of the Sindbis replicon system as an Env-targeted HIV vaccine.
Center RJ; Miller A; Wheatley AK; Campbell SM; Siebentritt C; Purcell DF
Vaccine; 2013 Apr; 31(18):2260-6. PubMed ID: 23499600
[TBL] [Abstract][Full Text] [Related]
14. A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles.
Pan CH; Greer CE; Hauer D; Legg HS; Lee EY; Bergen MJ; Lau B; Adams RJ; Polo JM; Griffin DE
J Virol; 2010 Apr; 84(8):3798-807. PubMed ID: 20130066
[TBL] [Abstract][Full Text] [Related]
15. Long-term protection in hamsters against human parainfluenza virus type 3 following mucosal or combinations of mucosal and systemic immunizations with chimeric alphavirus-based replicon particles.
Greer CE; Zhou F; Goodsell A; Legg HS; Tang Z; zur Megede J; Uematsu Y; Polo JM; Vajdy M
Scand J Immunol; 2007 Dec; 66(6):645-53. PubMed ID: 17944814
[TBL] [Abstract][Full Text] [Related]
16. Engineered alphavirus replicon vaccines based on known attenuated viral mutants show limited effects on immunogenicity.
Maruggi G; Shaw CA; Otten GR; Mason PW; Beard CW
Virology; 2013 Dec; 447(1-2):254-64. PubMed ID: 24210122
[TBL] [Abstract][Full Text] [Related]
17. Structure and immunogenicity of alternative forms of the simian immunodeficiency virus gag protein expressed using Venezuelan equine encephalitis virus replicon particles.
Cecil C; West A; Collier M; Jurgens C; Madden V; Whitmore A; Johnston R; Moore DT; Swanstrom R; Davis NL
Virology; 2007 Jun; 362(2):362-73. PubMed ID: 17275057
[TBL] [Abstract][Full Text] [Related]
18. Eradication of established tumors by vaccination with Venezuelan equine encephalitis virus replicon particles delivering human papillomavirus 16 E7 RNA.
Velders MP; McElhiney S; Cassetti MC; Eiben GL; Higgins T; Kovacs GR; Elmishad AG; Kast WM; Smith LR
Cancer Res; 2001 Nov; 61(21):7861-7. PubMed ID: 11691804
[TBL] [Abstract][Full Text] [Related]
19. Expression of the two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles.
Balasuriya UB; Heidner HW; Hedges JF; Williams JC; Davis NL; Johnston RE; MacLachlan NJ
J Virol; 2000 Nov; 74(22):10623-30. PubMed ID: 11044106
[TBL] [Abstract][Full Text] [Related]
20. Noncytopathic replication of Venezuelan equine encephalitis virus and eastern equine encephalitis virus replicons in Mammalian cells.
Petrakova O; Volkova E; Gorchakov R; Paessler S; Kinney RM; Frolov I
J Virol; 2005 Jun; 79(12):7597-608. PubMed ID: 15919912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
